World Markets Healthcare

Identify the next growth opportunity

Can you keep pace with shifting policy and market dynamics? Need to optimize your growth strategy? Do you know the competitive landscape for a particular product?

This online service provides a comprehensive and truly global view of the industry with headline analysis, forecasts, and country reports. Seamlessly analyze changes in the regulatory and business landscape to:

Rank and size markets
Plan budgets and sales with great accuracy
Hedge exposure to market risk
Optimize R & D processes
Secure market access and grow your business
Monitor business development opportunities and activities
Strengthen competitive intelligence

What’s Included

Analysis and Data

Headline Analysis
Global daily coverage of all key events, customizable by country, sector or topics covering all key events

Special Reports
Global and regional industry/market trends, drug class or therapeutic area news, biosimilars and generics developments, private insurance markets, and executive briefings on key global developments

Generics and Biosimilars
Approved and pipeline biosimilars, with analysis of litigation outcomes for top-selling branded pharmaceuticals in the United States

Country Reports
Daily updates for 69 countries, covering these topics:

Demographic/health trends
Health care provision infrastructure overview
Key legislative, regulatory and expenditure changes
Pharmaceutical market structure and outlook
Key market forecasts
Major market SWOT tables

Country Forecasts

Derived from world-renowned economic modeling, including:

Ten-year expenditure and sales forecasts (50+ countries)
Top-line SWOT tables
Executive briefings on forecast updates

Solve Your Business Challenge

Challenge	Solution
I need to understand new market entry risks and opportunities.	Use our Market Access Risk Scores (MARS) to assess complete entry risk in more than 65 countries.
How can I easily monitor multiple sources to keep pace with healthcare market trends?	Leverage our service to monitor competitors, R&D, investments, partnerships and regulatory issues.
I need to get a quick and accurate picture of a particular market.	Our SWOT tables, integrated into our country reports, provide a complete market overview, helping you plan with confidence.
I need to hedge my exposure in a contracting market.	Leverage forecasts to plan sales and budgets with greater accuracy. Distill our analysis and historical data to understand healthcare market drivers country-wide.
Generics and biosimilars are changing my market dynamics. How do I stay on top of these changes?	Access detailed data on the generics and biosimilars market, including pipeline and approved drugs. Stay informed with a litigation-tracking database.

Why Technology is Not a Silver Bullet When It Comes to Diabetes

The evolution of insulin has undergone a tremendous change, from multiple injections routines to continuous subcutaneous insulin infusion through pumps. Pharmaceutical companies have been very active in inventing better methods of drug delivery, reducing the overall dose frequency and launching re-usable delivery systems. Unfortunately, two of the most powerful practices aren’t widely used: making lifestyle changes and adhering to regimens that regulate blood-sugar levels. These behaviors lower health costs and extend quality of life for diabetes patients, but patient buy-in has remained low on both.

Click sections below to explore current trends.

Experts

Tim Dall

Managing Director - Consulting, Life Sciences, Economics and Country Risk, IHS Markit

Gustav Ando

Senior Director & Vice President, Life Sciences, IHS Markit

Milena Izmirlieva

Senior Manager, Life Sciences Research, IHS Markit

Praful Mehta

Associate Director – Life Sciences Strategy & Innovation, IHS Markit

Industry Success Stories

XL Catlin “Finds the Good Risks in Difficult Places” and Cuts Costs 20% by Consolidating Research to One Source

A global insurance industry leader brought efficiency to risk selection by standardizing with one information provider across all underwriting decisions. This firm thereby reduced research costs by 20%, established a ‘center of excellence’ internally and fueled growth by gaining insights to write risk in areas where others held back.

Learn more about our customer’s success

Airbus Publishes 20 Year Forecast, "Flying on Demand" – Confirms Strong Growth in Commercial Aviation Markets

This premier aircraft manufacturer produced Flying on Demand, Global Market Forecast 2014-2033, a reference book that provides comprehensive economic, financial and political coverage of 200-plus countries. Stakeholders throughout the commercial airline industry rely on the book’s insights regarding product innovation, production and planning.

Learn more about our customer’s success

IFI Advisory uses reliable risk assessments to sustain highly competitive position in the international marketplace

IFI Advisory is a global leader in risk management consulting and supports companies in their development projects. In this brief video, IFI Advisory CEO Romolo Pacifico explains why he trusts Jane’s by IHS Markit to provide accurate and up-to-date information, and what Jane’s means to his business.

View Video

Baker Hughes accurately forecasted falling oil prices to enable better strategic business decisions

One of the world’s largest oilfield service providers enhanced the forecasting accuracy of its oil rig count model from 90 to 97.6 percent, predicted the impact of price changes on customer spending and demand for product lines (by leveraging 3,500 factors) and created a model that predicted the deflation of WTI crude oil prices in late 2014.

SEE CASE STUDY